A dose block-randomized, double blinded, placebo controlled, dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetics after single oral doses of AVI-CO-004 in healthy male subject

Trial Profile

A dose block-randomized, double blinded, placebo controlled, dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetics after single oral doses of AVI-CO-004 in healthy male subject

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs AVI CO 004 (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors Avixgen
  • Most Recent Events

    • 11 Nov 2016 Status changed from recruiting to completed.
    • 28 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top